What Is a Liquid Biopsy?

A liquid biopsy is a blood test that detects cancer-related materials circulating in the bloodstream, such as:

• Circulating Tumor DNA (ctDNA): Small fragments of DNA shed by cancer cells.
• Circulating Tumor Cells (CTCs): Whole cancer cells that have broken away from a tumor.
• Exosomes / RNA fragments: Tiny vesicles released by cancer cells.

Unlike traditional biopsies that require tissue removal through surgery or a needle, liquid biopsies are minimally invasive and can provide valuable genetic and molecular information from just a blood sample.

 

How Liquid Biopsy Is Used in Cancer

1. Detection & Diagnosis

• Helps identify the presence of cancer when combined with other tests.
• Still emerging as a screening tool but promising for early cancer detection.

2. Treatment Selection (Precision Medicine)

• Provides tumor genetic information (via NGS of ctDNA) to guide targeted therapy or immunotherapy choices.

3. Monitoring

• Tracks tumor evolution and treatment response in real time.
• Detects minimal residual disease (MRD) after surgery or treatment.
• Identifies relapse or recurrence earlier than imaging.

4. Resistance Detection

• Finds new mutations that explain why treatment stopped working.
• Guides changes in therapy when cancer becomes resistant.

 

What to Expect During the Test

• A simple blood draw (usually from a vein in the arm).
• Sample is sent to a laboratory for advanced molecular analysis (often using NGS).
• Results may take 1–3 weeks depending on the test.

 

Benefits

• Minimally invasive — only a blood sample needed.
• Can be repeated often, making it ideal for ongoing monitoring.
• Detects cancer heterogeneity (mutations from multiple tumor sites).
• May reveal changes missed by a single tissue biopsy.

 

Risks & Limitations

• May not detect cancer if too little ctDNA/CTCs are present (false negatives).
• Not yet a complete replacement for tissue biopsy — tissue is still needed for initial diagnosis in most cases.
• Limited availability in some regions and may be costly.
• Some results may be difficult to interpret without context from imaging or pathology.

 

Alternatives & Related Tests

• Tissue Biopsy: Gold standard for initial diagnosis.
• NGS (Next-Generation Sequencing): Can be applied to both tissue and liquid biopsies.
• Imaging (CT, MRI, PET, Ultrasound): Shows location and size of tumors but not molecular details.

 

Questions to Ask Your Doctor

• Can a liquid biopsy replace a tissue biopsy in my case?
• How will the results affect my treatment plan?
• Should I have liquid biopsies regularly during treatment?
• What specific cancer markers or mutations will this test look for?
• Will insurance cover the cost of this test?

 

Patient Tips

• Ask whether the test being offered is validated for your cancer type.
• Keep a record of all test results — they may guide treatment later.
• Use liquid biopsy results in combination with tissue biopsy and imaging for the most complete picture.
• Consider clinical trials — many are evaluating liquid biopsy in early detection and monitoring.

 

References

• National Cancer Institute (NCI): Liquid Biopsy for Cancer
• American Cancer Society: Blood Tests for Cancer
• FDA: Approved Liquid Biopsy Tests